Key facts
- Notable investors include ANRI, Coral Capital..
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Ruten
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruten are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruten
Developer of medical devices designed to establish reconstructive treatments for conditions where standard options are either infeasible or ineffective. The company's technology is working on an invasive brain-machine interface (BMI) to rebuild various bodily functions lost due to illness, disease, or accidents, enabling medical experts to address unmet medical needs.
- Sector
- Healthcare
- HQ
- Naperville, IL, United States
- Founded
- 2023
- Employees
- 8
- Website
- ruten-neuro.com/
- Ownership
- Privately Held (backing)
Ruten doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruten shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruten in its N-PORT filings yet. We sweep new filings monthly.